New drug aims to reduce protein leak in kidney disease patients
Disease control
Recruiting now
This study tests an investigational drug called WAL0921 in adults with certain kidney diseases that cause protein in the urine. About 96 participants will receive either the drug or a placebo as an IV infusion every two weeks for 14 weeks. The goal is to see if the drug is safe a…
Phase: PHASE2 • Sponsor: Walden Biosciences • Aim: Disease control
Last updated May 17, 2026 10:44 UTC